Patrice Louvet Sold 49226 shares of Procter & Gamble Co (PG) in an Insider Trade; Broadfin Capital Upped Its Endo Intl Plc (ENDP) Holding

May 24, 2017 - By Clifton Ray

Broadfin Capital Llc increased Endo Intl Plc (ENDP) stake by 7.25% reported in 2016Q4 SEC filing. Broadfin Capital Llc acquired 105,500 shares as Endo Intl Plc (ENDP)’s stock declined 9.17%. The Broadfin Capital Llc holds 1.56M shares with $25.69 million value, up from 1.45M last quarter. Endo Intl Plc now has $2.87B valuation. The stock declined 2.33% or $0.3 reaching $12.58 on the news. About 3.84M shares traded. Endo International plc – Ordinary Shares (NASDAQ:ENDP) has declined 19.57% since May 24, 2016 and is downtrending. It has underperformed by 36.27% the S&P500.

Procter & Gamble Co’s Group President – Global Beauty, Patrice Louvet, sold 49,226 shares of stock in the public firm. The shares average cost was $86.5, for full trade value of $4,256,117 US Dollars. She also sold 95,808 shares that are worth approx $8,260,851 USD in the last 30 days. Obviously, the stocks unloading attracted interest, as Mr. Patrice right now has ownership of 52,528 shares, accounting for 0.00% of Procter & Gamble Co’s total market capitalization. This trade, which was filled on 24/05/2017 was disclosed in a report with the SEC.

Among 19 analysts covering Endo International plc (NASDAQ:ENDP), 9 have Buy rating, 0 Sell and 10 Hold. Therefore 47% are positive. Endo International plc had 43 analyst reports since August 11, 2015 according to SRatingsIntel. Deutsche Bank maintained the stock with “Buy” rating in Friday, March 18 report. The company was initiated on Tuesday, September 29 by Nomura. The firm has “Outperform” rating given on Thursday, September 29 by Northland Capital. The company was upgraded on Monday, June 13 by Mizuho. The stock has “Buy” rating by Citigroup on Friday, April 29. The company was maintained on Tuesday, January 31 by Mizuho. The firm has “Positive” rating by Susquehanna given on Thursday, November 10. JP Morgan maintained it with “Overweight” rating and $65 target in Monday, March 21 report. The firm earned “Equal Weight” rating on Friday, May 6 by Barclays Capital. The rating was maintained by Citigroup on Friday, September 16 with “Buy”.

Broadfin Capital Llc decreased Mirati Therapeutics Inc (NASDAQ:MRTX) stake by 173,999 shares to 826,001 valued at $3.92M in 2016Q4. It also reduced Advaxis Inc (NASDAQ:ADXS) stake by 45,420 shares and now owns 1.52M shares. Trupanion Inc (NYSE:TRUP) was reduced too.

Investors sentiment increased to 1.25 in 2016 Q4. Its up 0.48, from 0.77 in 2016Q3. It increased, as 36 investors sold ENDP shares while 86 reduced holdings. 51 funds opened positions while 102 raised stakes. 204.75 million shares or 9.79% more from 186.48 million shares in 2016Q3 were reported. Kamunting Street Cap Mgmt Limited Partnership invested in 193,740 shares. Oak Associates Limited Oh invested 0.23% in Endo International plc – Ordinary Shares (NASDAQ:ENDP). New Mexico Educational Retirement Board reported 20,700 shares. Next Financial stated it has 933 shares or 0% of all its holdings. Tpg Group (Sbs) has invested 3.94% in Endo International plc – Ordinary Shares (NASDAQ:ENDP). Swiss State Bank invested in 0.02% or 584,863 shares. Teachers Retirement Sys Of The State Of Kentucky invested in 0.01% or 28,000 shares. 84,533 were reported by Engineers Gate Manager L P. California State Teachers Retirement Systems has 0.01% invested in Endo International plc – Ordinary Shares (NASDAQ:ENDP). Wells Fargo & Mn holds 0% in Endo International plc – Ordinary Shares (NASDAQ:ENDP) or 160,423 shares. 174,568 are held by Caisse De Depot Et Placement Du Quebec. 11,484 were accumulated by Profund Advsr Ltd Liability. 1832 Asset Mngmt Ltd Partnership reported 1,820 shares. Wellington Gru Limited Liability Partnership holds 2.18M shares. Ny State Common Retirement Fund holds 774,045 shares or 0.02% of its portfolio.

Since February 2, 2017, it had 0 insider purchases, and 17 selling transactions for $15.80 million activity. 4,447 shares were sold by Pritchard Marc S., worth $405,526 on Wednesday, February 15. Matthew Price sold 3,833 shares worth $349,706. The insider Sheppard Valarie L sold 23,512 shares worth $2.13 million. $5.38 million worth of Procter & Gamble Co (NYSE:PG) was sold by Louvet Patrice on Wednesday, May 17. 5,000 shares valued at $440,000 were sold by Posada Juan Fernando on Thursday, February 2. Bishop Steven D sold $233,011 worth of stock or 2,668 shares. 965 shares valued at $88,011 were sold by TASTAD CAROLYN M on Wednesday, February 15.

Investors sentiment decreased to 0.85 in Q4 2016. Its down 0.03, from 0.88 in 2016Q3. It is negative, as 89 investors sold Procter & Gamble Co shares while 777 reduced holdings. 122 funds opened positions while 614 raised stakes. 1.48 billion shares or 15.87% less from 1.76 billion shares in 2016Q3 were reported. Delta Asset Limited Liability Tn holds 266,463 shares or 3.75% of its portfolio. Bahl Gaynor has 2.77M shares for 2.85% of their portfolio. Moreover, Kanaly has 0.57% invested in Procter & Gamble Co (NYSE:PG) for 31,918 shares. Crossvault Capital reported 46,072 shares. Mai Cap Mgmt reported 0.89% in Procter & Gamble Co (NYSE:PG). Argi Invest Service Ltd Liability reported 74,087 shares stake. Main Street Ltd has 5.3% invested in Procter & Gamble Co (NYSE:PG). Northstar Gp invested in 18,416 shares or 1.07% of the stock. Colony Ltd Company holds 0.14% or 14,956 shares. Kdi Ptnrs Limited Liability Corp invested 0.48% in Procter & Gamble Co (NYSE:PG). 78,454 are owned by Evercore Wealth Mngmt Ltd Com. Raymond James Fincl Svcs reported 0.5% stake. Cape Ann Savings Bank invested 1.82% of its portfolio in Procter & Gamble Co (NYSE:PG). Eagleclaw Capital Managment Ltd Liability reported 6,145 shares. Ingalls Snyder Ltd reported 390,901 shares.

About 2.15 million shares traded. Procter & Gamble Co (NYSE:PG) has risen 7.54% since May 24, 2016 and is uptrending. It has underperformed by 9.16% the S&P500.

Among 22 analysts covering Proctor & Gamble (NYSE:PG), 10 have Buy rating, 1 Sell and 11 Hold. Therefore 45% are positive. Proctor & Gamble has $106 highest and $61.0 lowest target. $89.24’s average target is 3.39% above currents $86.31 stock price. Proctor & Gamble had 47 analyst reports since August 4, 2015 according to SRatingsIntel. The firm earned “Neutral” rating on Monday, October 26 by UBS. Vetr downgraded it to “Strong-Buy” rating and $82.80 target in Friday, August 7 report. Stifel Nicolaus maintained Procter & Gamble Co (NYSE:PG) on Friday, July 22 with “Buy” rating. The firm has “Buy” rating given on Tuesday, August 25 by Vetr. The firm has “Overweight” rating by Barclays Capital given on Thursday, October 29. The company was downgraded on Tuesday, August 4 by TheStreet. Citigroup maintained Procter & Gamble Co (NYSE:PG) rating on Thursday, August 4. Citigroup has “Buy” rating and $98 target. The rating was maintained by B. Riley & Co with “Neutral” on Monday, October 26. The rating was upgraded by B. Riley & Co on Monday, August 15 to “Buy”. The rating was maintained by Barclays Capital on Monday, March 21 with “Equal-Weight”.

Analysts await Procter & Gamble Co (NYSE:PG) to report earnings on August, 1. They expect $0.79 EPS, 0.00% or $0.00 from last year’s $0.79 per share. PG’s profit will be $2.02B for 27.31 P/E if the $0.79 EPS becomes a reality. After $0.96 actual EPS reported by Procter & Gamble Co for the previous quarter, Wall Street now forecasts -17.71% negative EPS growth.